Increased Circulating FGF23 Does Not Lead to Cardiac Hypertrophy in the Male Hyp Mouse Model of XLH

Serum levels of fibroblast growth factor 23 (FGF23) markedly increase with renal impairment, with FGF23 levels correlating with the presence of left ventricular hypertrophy (LVH) and mortality in patients with chronic kidney disease (CKD). FGF23 activates calcineurin/nuclear factor of activated T ce...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Endocrinology
Main Authors: Liu, Eva S, Thoonen, Robrecht, Petit, Elizabeth, Yu, Binglan, Buys, Emmanuel S, Scherrer-Crosbie, Marielle, Demay, Marie B
Formato: Artigo
Idioma:Inglês
Publicado: Endocrine Society 2018
Assuntos:
Research Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC5915960/
https://ncbi.nlm.nih.gov/pubmed/29635291
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/en.2018-00174
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares